다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
RAPT Therapeutics Inc (RAPT)
RAPT Therapeutics Inc (RAPT) 뉴스

RAPT

RAPT Therapeutics (RAPT)

RAPT Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RAPT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/10	01:00	GlobeNewswire Inc.	RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/03/08	06:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/03/07	22:08	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/03/07	22:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/03/07	22:00	GlobeNewswire Inc.	RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/03/06	06:30	GlobeNewswire Inc.	RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/02/23	07:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/02/21	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/02/20	21:30	GlobeNewswire Inc.	RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/02/14	22:52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/02/13	22:00	GlobeNewswire Inc.	RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/01/31	22:00	GlobeNewswire Inc.	RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:RAPT	RAPT Therapeutics Inc
2024/01/02	22:00	GlobeNewswire Inc.	RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/27	22:00	GlobeNewswire Inc.	RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/13	22:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/13	22:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/13	22:00	GlobeNewswire Inc.	RAPT Therapeutics Reports Third Quarter 2023 Financial Results	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/04	01:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/04	01:00	GlobeNewswire Inc.	RAPT Therapeutics Announces Positive Data, Including Objective Response Rates and Progression-Free Survival, from its Phase 2 Trial of FLX475 in Combination with a Checkpoint Inhibitor in Patients with Advanced NSCLC	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/11/02	05:05	GlobeNewswire Inc.	RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in November	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/10/24	05:40	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/10/18	22:00	GlobeNewswire Inc.	RAPT Therapeutics Announces Two FLX475 Presentations at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/31	05:05	GlobeNewswire Inc.	RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/18	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/12	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/11	21:57	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/11	21:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/11	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/08/11	21:00	GlobeNewswire Inc.	RAPT Therapeutics Reports Second Quarter 2023 Financial Results	NASDAQ:RAPT	RAPT Therapeutics Inc
2023/06/07	21:00	GlobeNewswire Inc.	RAPT Therapeutics to Participate in the Goldman Sachs Global Healthcare Conference	NASDAQ:RAPT	RAPT Therapeutics Inc

검색 관련기사 보기:NASDAQ:RAPT

1 2 3 4 5 6 7 8 9 10 다음 >>

Health Care Select Sector

US Dollar vs Sterling

Invesco QQQ Trust Series 1

Financial Select Sector

BNP Paribas (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관